US Broker Ratings

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A 135.75% Potential Upside for Investors in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its promising pipeline of cancer therapies and an enticing potential upside of 135.75% based on analyst target prices...

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 189% Upside for Investors

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with a staggering potential upside of 189.31%, according to the latest analyst ratings. Operating in the dynamic biotechnology industry, Verastem..

Claritev Corporation (CTEV) Stock Analysis: A Promising 64% Upside in Healthcare Tech

Claritev Corporation (NASDAQ: CTEV) is capturing the attention of investors with its significant potential upside, despite recent price fluctuations. The healthcare technology company, valued at $411.58 million, specializes in providing..

AbCellera Biologics Inc. (ABCL)

⚠️ No article content returned.

..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Biotech’s 121.89% Potential Upside Captivates Investors

In the dynamic landscape of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) emerges as a compelling opportunity for investors seeking high-growth potential in the healthcare sector. Boasting a market capitalization of..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenging Waters with a Pioneering Vision

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is currently navigating a complex market environment. With a market capitalization of $672.2 million, the company is..

Akso Health Group (AHG) Stock Analysis: A Closer Look at Market Position and Revenue Growth

Investors eyeing the healthcare sector may find Akso Health Group (NASDAQ: AHG) an intriguing prospect. With a market capitalization of $1.76 billion, this China-based company operates primarily in the medical..

Bioventus Inc. (BVS) Stock Analysis: Unpacking a 38.97% Potential Upside in the Medical Devices Sector

For investors keen on the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a captivating opportunity within the medical devices industry. This Durham, North Carolina-based company is dedicated to innovating solutions..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Evaluating a Biotech with a 61% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention within the biotechnology sector, not just for its innovative approach to treating diseases with unmet medical needs but also for its compelling..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Navigating Growth Amidst a -0.14% Potential Downside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is a burgeoning player in the biotechnology sector, focusing on developing innovative treatments for pediatric and adult diseases. With a market capitalization of $2.22..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Promising 88% Upside in Healthcare Genomics

Personalis, Inc. (NASDAQ: PSNL), a pivotal player in the healthcare sector specializing in diagnostics and research, offers a compelling opportunity for investors intrigued by the burgeoning field of cancer genomics...

PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations

PureTech Health plc (PRTC), a dynamic player in the biotechnology industry, is making waves with its innovative pipeline despite facing financial challenges. As a company based in Boston, Massachusetts, PureTech..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 234% Potential Upside

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at revolutionizing cancer treatment. Headquartered in San Diego, California, Kura..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a Focus on Talent Management Services

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare sector, primarily operates within the medical care facilities industry in the United States. With a market capitalization of..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 166.97% Potential Upside in Biotech Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands out as a compelling opportunity within the biotechnology sector, offering a remarkable potential upside of 166.97%. With a market capitalization of $537.85 million, this clinical-stage..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 128.92% Upside in the Biotech Sector

For investors seeking opportunities in the high-stakes world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing proposition. With a current market capitalization of $1.48 billion, this U.S.-based biopharmaceutical company..

Embecta Corp. (EMBC) Stock Analysis: A High Dividend Yield and Potential Upside of 122.22%

Embecta Corp. (NASDAQ: EMBC) presents an intriguing opportunity for investors, particularly those with a keen eye for high-yield dividends and significant potential upside. Operating in the healthcare sector, specifically within..

Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a Potential 121% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering entity in the healthcare sector, is drawing investor attention with its innovative approach to medical devices, particularly in the field of bunion..

EyePoint, Inc. (EYPT) Stock Analysis: A Biotech Gem with 177% Potential Upside

EyePoint, Inc. (EYPT), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating serious retinal diseases. With a market capitalization of $1.12 billion, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds